{
    "code": 0,
    "data": [
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith the transcript of the investor conference call for Q3 & 9M FY26 held on February 3 2026.",
            "news_id": "ba0b4eff-6425-488f-bed4-7a565f2515ce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49858517-2821-4378-ab5b-bee857346a00.pdf",
            "news_date": "2026-02-09 13:37:43",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find attached intimation containing link of the Audio Recording-Investor Conference Call for Q3 & 9M FY26",
            "news_id": "30d0011c-f58f-431f-b8e2-53768c6a7160",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4eaabab0-76f0-465a-b532-c0cf52275450.pdf",
            "news_date": "2026-02-03 21:53:40",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation of Q3 FY26 for financial results",
            "news_id": "9b3e476f-253c-40f3-9287-6e64fd5e605f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa7f58c8-bb30-43c8-8184-df124142ee0b.pdf",
            "news_date": "2026-02-03 16:21:57",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Please find attached the Unaudited Financial Results for the quarter and nine months ended December 31 2025",
            "news_id": "25cb75c5-d312-48cd-a3f2-9709e6610ae7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86b2b3ea-b33a-4bb0-9c64-b6298be2e468.pdf",
            "news_date": "2026-02-03 16:14:32",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith transcript of the investor Conference Call for Q2 & H1 FY 26",
            "news_id": "7df9e816-0071-4ebb-a634-0430b9ed2bd4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09896907-dd89-468c-869d-25ae30374415.pdf",
            "news_date": "2025-11-11 17:49:48",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find attached intimation containing link of the Audio Recording-Investor Conference Call for Q2H1FY26",
            "news_id": "4cbea6fc-a40c-4026-96ef-cbd1748d797d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c33b4f6-3848-4e7e-8dc8-dcca5865bb30.pdf",
            "news_date": "2025-11-06 20:00:11",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Financial Results for the quarter and half year ended 30th September 2025",
            "news_id": "a430f5a9-0f8f-499b-8e59-a51accee2ee1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=740ea2bd-a613-4c62-b450-70ab75a552ed.pdf",
            "news_date": "2025-11-06 16:38:44",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q2FY26",
            "news_id": "35772d03-89be-469f-ae60-90a64e5f6814",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7951849a-2f16-43f2-a94b-a1740f7d2ca1.pdf",
            "news_date": "2025-11-06 16:30:39",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith transcript of the Investor Conference Call for Q1 FY26 held on August 1 2025",
            "news_id": "b1209c74-ca53-4689-969b-d91e99c15d04",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c81dfdb-7723-4f42-a476-4753e4c7086b.pdf",
            "news_date": "2025-08-06 23:20:46",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Investor Conference Call for Q1 & FY26 - Audio Recording",
            "news_id": "42809223-c415-4f25-86a5-031bd1c62699",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71c3a3ab-2448-4ed0-935e-1b9701933035.pdf",
            "news_date": "2025-08-01 15:06:11",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached Investor Presentation",
            "news_id": "30360094-d2ed-4317-8340-a89d62e3c20c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9390a370-5720-4b96-8d2c-d1065a2ab458.pdf",
            "news_date": "2025-07-31 17:54:11",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter Ended On June 30 2025",
            "news_body": "Please find attached un-audited financial results for the quarter ended on June 30 2025",
            "news_id": "a42f129a-129f-4180-ba39-ccc0ad311ec5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2571e45e-4fa5-4ba5-8739-771a36c4ba7e.pdf",
            "news_date": "2025-07-31 17:50:01",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Investor Conference Call for Q4 & FY25 - Transcript",
            "news_id": "af8061e8-6a3f-499e-9038-3359da4d21e3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6d2d808-2fb6-4350-a73a-0df90d043dfa.pdf",
            "news_date": "2025-05-27 15:11:34",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Investor Conference Call for Q4 & FY25 - Audio Recording",
            "news_id": "8c4a4b4c-8825-4e75-8d5b-80c32c841d6c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16d5125f-cd4f-45b9-bb3a-65674a6c0eaf.pdf",
            "news_date": "2025-05-21 20:39:34",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "65107d92-cb35-4fc1-a026-1b3f07b97111",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf4d04fa-6dcd-4aa0-aab0-8add14647615.pdf",
            "news_date": "2025-05-21 18:19:25",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation of Q4FY25",
            "news_id": "e2b781e1-0008-446b-b77a-62686fd294d6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e768a11-e3f8-46fe-be52-d95b8ea90c41.pdf",
            "news_date": "2025-05-21 18:07:53",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "1f8b4f14-67ca-4305-97ee-a68dc314b23c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5caf3035-d446-4f0b-9125-65393dca8fd5.pdf",
            "news_date": "2025-05-21 18:05:07",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Investor Conference Call for Q3 & 9M FY25 - Transcript",
            "news_id": "6cc0b2ec-a7f0-4dfd-ba54-9ebd94598852",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09cab4ef-bf88-40b1-be1e-cabdff929690.pdf",
            "news_date": "2025-01-30 15:12:00",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q3FY25",
            "news_id": "16360e86-20bf-428b-832b-4b8fd6232522",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f508c34-1b16-40d2-b8e9-55cea708bdcf.pdf",
            "news_date": "2025-01-23 19:54:20",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Investor Conference Call for Q2 & H1FY25 - Transcript",
            "news_id": "054f2d2d-e42b-4caf-81ea-ff803e2b716e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1fde1a79-c646-4353-b99b-69b0f12d9383.pdf",
            "news_date": "2024-11-11 18:20:53",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Investor Conference Call for Q2 & H1 FY25 - Audio Recording",
            "news_id": "24fcfee7-0b76-406b-ab81-ae8064e4317a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=223ff998-8c61-443b-9f60-c34f38769011.pdf",
            "news_date": "2024-11-05 21:43:47",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation  for Q2FY25",
            "news_id": "3db4cba1-36ec-4b13-a811-9734529d94bf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf840817-d664-47d4-858e-990b6fa71162.pdf",
            "news_date": "2024-11-05 16:39:56",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held Today I.E. November 5, 2024",
            "news_body": "Outcome of Board Meeting held today i.e. November 5, 2024",
            "news_id": "bd998fce-4dc8-4d49-9731-c4f172bfc147",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a35920d7-fea8-49a2-abe8-1d28afb26b80.pdf",
            "news_date": "2024-11-05 16:30:05",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation for the information of Investors",
            "news_id": "f6bd3b9e-9669-4a28-93bc-ed6d5cddad7b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87dce799-cad1-4805-8128-4d819376836c.pdf",
            "news_date": "2024-09-02 17:31:37",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation at 20th Annual Global Investor Conference Organized by Motilal Ostwal",
            "news_id": "6a04c5c7-4c19-4c2a-8d03-d88fa717aea2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48686b39-01f2-4ab2-a614-0378c6d56f6c.pdf",
            "news_date": "2024-08-20 07:29:52",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation at 20th Annual Global Investor Conference Organized by Motilal Ostwal",
            "news_id": "82dd5323-a128-42b8-be09-79b630c58d21",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed70faa4-fc89-4b4a-a787-b72ae2e67a98.pdf",
            "news_date": "2024-08-20 07:28:28",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Investor Conference Call for Q1FY25- Transcript",
            "news_id": "ebbed0e6-1896-4614-b395-086ee9b1acb4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d30e4d4-4e89-464c-bc32-91c670ef6391.pdf",
            "news_date": "2024-08-06 18:04:44",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Investor Conference Call for Q1FY25- Audio Recording",
            "news_id": "49b5f028-159a-4c32-9c1c-bc3d8f7c1ec4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff718367-b61a-4cb7-9ace-d0914d6b48ff.pdf",
            "news_date": "2024-07-31 20:47:02",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Financial Results of the Company for the quarter ended on June 30, 2024.",
            "news_id": "bb963b8e-4c4e-4a61-bd15-d756891d3689",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=442aa76b-b1ba-4c21-ba47-2eab3db99062.pdf",
            "news_date": "2024-07-31 15:02:41",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held Today I.E. July 31, 2024",
            "news_body": "Outcome of Board Meeting- Financial Results for the quarter ended June 30, 2024.",
            "news_id": "6ea6c394-a451-4dc8-bb22-b8009a87be69",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=416167a9-edcf-4b2f-a6a5-39f8728d1708.pdf",
            "news_date": "2024-07-31 14:47:04",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call held on July 26, 2024 at 05:00 p.m. in relation to acquisition of 100% stake in Bharat Serums and Vaccines Limited",
            "news_id": "72592a98-774d-4bc8-8d73-8649c6c6c5b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c181d00-75e8-4295-9156-0ba481f74f91.pdf",
            "news_date": "2024-07-27 13:42:47",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Mankind Pharma to acquire 100% stake in BSV",
            "news_id": "629a529e-d399-4e5b-9fcf-62c18c1fae7b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bee6639e-6050-4df2-a8d1-e1fcb6cfd5a5.pdf",
            "news_date": "2024-07-25 22:09:38",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Investor Conference Call for Q4FY24 - Transcript",
            "news_id": "a9747884-846f-4aaf-ae3e-e65d0a29223c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7a58344-29d8-4a71-baac-2e6db4d892a0.pdf",
            "news_date": "2024-05-22 14:45:53",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Investor Conference Call for Q4FY24 - Audio Recording",
            "news_id": "71aa8510-250c-4591-9420-d3539dac5865",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4bcb9ac8-2211-4578-ad64-c0cf0fb796e4.pdf",
            "news_date": "2024-05-16 18:41:20",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter and financial year ended 31st March 2024.",
            "news_id": "47a6a321-cd3e-4fa1-8abe-c130016ef737",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06376baa-a3ae-4608-91d0-4d6cf3af34f2.pdf",
            "news_date": "2024-05-15 19:41:20",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Regulation 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations').",
            "news_body": "Outcome of Board Meeting held today i.e. May 15, 2024",
            "news_id": "d3f9aebb-8193-4869-8fb3-103dccf6f168",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d053d67-d33e-4e84-b6fa-60c29bb40f08.pdf",
            "news_date": "2024-05-15 18:17:57",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Investor Conference Call for Q3 FY24 - Transcript",
            "news_id": "02d53c7a-7631-45ee-ac0e-811b2694e58d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3f32017-1f45-48a7-aa5f-6c6150aa31cf.pdf",
            "news_date": "2024-02-07 15:33:09",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Investor Conference Call for Q3 FY24- Audio Recording",
            "news_id": "4cef3a76-2a30-49e2-843a-3f471184029f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6a6e888-3537-46c2-9caa-7385bffb91f3.pdf",
            "news_date": "2024-02-02 16:11:02",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Financial Results of Q3 FY24",
            "news_id": "2062e94b-1947-436e-aaa0-894747ef3e33",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ede6ee85-f8f2-4dc5-bce7-52cffbfd1659.pdf",
            "news_date": "2024-01-31 18:02:22",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held Today I.E. January 31, 2024",
            "news_body": "Outcome of Board Meeting held today i.e. January 31, 2024",
            "news_id": "2ae04ca0-1d86-43ce-921d-a5248a913cf1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=562a670e-210b-4cf0-84e3-26508413336b.pdf",
            "news_date": "2024-01-31 17:32:48",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation at 42nd Annual JP Morgan Healthcare Conference",
            "news_id": "c298a854-16f1-4b3a-9546-4dd98ecf9e27",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e62dd2c-fead-4e24-81f3-ec34f72b8f7f.pdf",
            "news_date": "2024-01-10 19:00:49",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, please find attached the transcript of the Investor Conference Call for Q2FY24 held on November 01, 2023.",
            "news_id": "2314bd8f-79f1-46c3-9adf-a01fd1e1473a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dbb2a66f-ad87-4ce6-9a07-70740af925ec.pdf",
            "news_date": "2023-11-07 16:58:38",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Investor Conference Call for Q2FY24 - Audio Recording",
            "news_id": "b8d4978c-a6a4-49e6-8709-876c1c920003",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0018f7ae-b389-45aa-bde6-ac796dffcfca.pdf",
            "news_date": "2023-11-01 16:30:08",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Financial Results of Q2FY23-24",
            "news_id": "62d04440-5313-4d7c-872d-cc11ab9079c7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02982d5d-b2ce-4cf2-a89d-f2bb6365c23e.pdf",
            "news_date": "2023-10-31 18:00:23",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held Today I.E. October 31, 2023",
            "news_body": "Outcome of Board Meeting held today i.e. October 31, 2023",
            "news_id": "b31ff714-199b-4893-bfff-550bfea4a66e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb68c5cc-6e38-4d6a-905e-d3ef9e57a4bf.pdf",
            "news_date": "2023-10-31 17:26:03",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the Investor Conference Call for Q1FY24 held on Thursday, August 03, 2023.",
            "news_id": "cd9abc52-5a14-42e5-974f-ad0a1bd6b000",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99cd547d-ee26-4dfe-b779-872eac23421a.pdf",
            "news_date": "2023-08-08 13:57:11",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated July 21, 2023 under subject 'Intimation of Investor Conference Call on Q1FY24 with Senior Management of Mankind Pharma Limited', the audio recording of the Performance and Business Update Call held today i.e. 03rd August 2023 is available on the website of the Company at https://www.mankindpharma.com/media/investor/kot1320230803148085-orignal-1691059985.mp3",
            "news_id": "2b7ae713-5d1c-468b-b8b0-7752996defde",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d8e5e05-8e03-42d2-a351-c07cd84fc0a4.pdf",
            "news_date": "2023-08-03 17:40:33",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation of Q1FY2023-24",
            "news_id": "f2fea323-586e-4524-a24b-e33f297525c3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42cc1661-75a1-44d4-97f9-ee49553d5d1e.pdf",
            "news_date": "2023-08-02 18:54:19",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. August 2, 2023",
            "news_body": "Outcome of Board Meeting as per letter attached",
            "news_id": "1cdf29f5-7601-4bd0-a059-a5a7a2135e4c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b75992a8-081a-4824-bcb7-9004650c7993.pdf",
            "news_date": "2023-08-02 18:16:36",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Regulation 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Outcome of Board Meeting as per letter attached.",
            "news_id": "b8bcde9c-c284-4563-b68d-666ca474ecf2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=886f507b-ab33-4fbe-85c3-de279bfdbdc6.pdf",
            "news_date": "2023-08-02 18:11:30",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the Performance and Business Update Call for Q4FY23 & FY23 held on Wednesday, 31st May 2023. The transcript is also available on the website of the Company at https://www.mankindpharma.com/media/investor/q4-fy23-transcript-1686050139.pdf",
            "news_id": "e55f420c-b40a-4051-aff6-514a856cd8de",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8a92a5d-2a2f-4be4-9fac-e3c66611afc5.pdf",
            "news_date": "2023-06-06 18:15:10",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated 25th May 2023 under subject 'Intimation of Performance and Business Update Call on Q4FY23 & FY23 with Senior Management of Mankind Pharma Limited', the audio recording of the Performance and Business Update Call held today i.e. 31st May 2023 is available on the website of the Company at https://www.mankindpharma.com/media/investor/kot1320230531147437-1685528185.mp3",
            "news_id": "2e855c47-e439-42d0-8739-ca4795a24ce8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c83cf737-2a82-4ade-9639-28a4a3d3618d.pdf",
            "news_date": "2023-05-31 18:37:39",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In reference to our intimation dated 25th May 2023 under subject 'Intimation of Performance and Business Update Call on Q4FY23 & FY 23 with Senior Management of Mankind Pharma Limited ('the Company')' and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the presentation that would be placed in a Performance and Business update call for Q4FY23 & FY 23 scheduled on Wednesday, 31st May 2023 at 12 noon (IST).The presentation is also being uploaded on the website of the company i.e. www.mankindpharma.com.",
            "news_id": "688a75a3-ca1a-45b1-bdef-311882eac6c5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c22100a-da67-4b8b-a47a-b88966354716.pdf",
            "news_date": "2023-05-30 19:31:02",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended On 31St March 2023",
            "news_body": "We are enclosing herewith as follows:a. Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended on 31st March 2023; b. Auditors' report with unmodified opinion on the audited Standalone and Consolidated Financial Results of the Company for the financial year ended on 31st March 2023; and c. The declaration from Chief Financial Officer pursuant to Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements), 2015, Regulations confirming the unmodified opinion of the statutory auditors on the audited Standalone and Consolidated Financial Results of the Company for the financial year ended on 31st March 2023.The meeting of Board of Directors of the Company commenced at 05:05 p.m. (IST) and concluded at 06:45 p.m.The above mentioned documents will also be available on the website of the Company at www.mankindpharma.com.",
            "news_id": "d6a79006-f11c-4eb6-90ee-e83359bdfd72",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1cafe8db-068a-4fad-bf10-73f683a5b350.pdf",
            "news_date": "2023-05-30 18:59:15",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}